Skip to main content
Erschienen in: World Journal of Urology 11/2023

28.09.2023 | Original Article

Patient compliance for metabolic evaluation and medical treatment (CoMET) in calcium-oxalate stone patients: prospective study by EULIS eCORE study group

verfasst von: Mehmet İlker Gökce, Selçuk Güven, Kremena Petkova, Tzevat Tefik, Muhammed Arif İbiş, Giray Sönmez, Nariman Gadzhiev, Murat Can Kiremit, Mehmet Ali Karagöz, Luca Villa, Kemal Sarıca

Erschienen in: World Journal of Urology | Ausgabe 11/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

In this study, we aimed to identify the compliance rates of calcium-oxalate stone patients for metabolic evaluation, diet and medical treatment and also determine the factors that are associated with poor compliance rates.

Methods

This study was conducted by the EULIS eCORE working group prospectively. In the initial visit, demographic and stone-related characteristics were recorded. Patients were suggested metabolic evaluation, dietary advices and medical treatment. Follow-up visit was performed after 3 months and compliance rates were recorded. Logistic regression analysis was performed to determine factors associated with poor compliance to metabolic evaluation, diet and medical treatment.

Results

Data of 346 patients from nine centers were analyzed. Compliance rates were 71.7%, 65.3%, and 63.7% for metabolic evaluation, diet, and medical treatment, respectively. In multivariate analysis, level of education (p = 0.003), history of emergency department visit (p = 0.04), number of stone surgeries (p = 0.03), patient care in dedicated stone clinic (p = 0.03), and history of shock wave lithotripsy (p = 0.005) were detected as independent predictors of compliance to metabolic analysis. Level of education (p < 0.001) and history of emergency department visit (p = 0.01) were detected as independent predictors of patient compliance to diet. Number of stone episodes (p = 0.03), family history of stones (p = 0.02), and polypharmacy (p < 0.001) were detected as independent predictors of patient compliance to medical treatment.

Conclusions

Patient compliance to metabolic evaluation, diet, and medical therapy is important for successful management of urolithiasis. Dietary advices and medications should be personalized by taking in to account the factors associated with poor compliance.
Literatur
1.
Zurück zum Zitat Tiselius HG (2016) Metabolic risk-evaluation and prevention of recurrence in stone disease: does it make sense? Urolithiasis 44(1):91–100CrossRefPubMed Tiselius HG (2016) Metabolic risk-evaluation and prevention of recurrence in stone disease: does it make sense? Urolithiasis 44(1):91–100CrossRefPubMed
2.
Zurück zum Zitat Parks JH, Coe FL (1996) The financial effects of kidney stone prevention. Kidney Int 50(5):1706–1712CrossRefPubMed Parks JH, Coe FL (1996) The financial effects of kidney stone prevention. Kidney Int 50(5):1706–1712CrossRefPubMed
3.
Zurück zum Zitat Kocvara R, Plasgura P, Petrik A et al (1999) A prospective study of nonmedical prophylaxis after a first kidney stone. BJU Int 84(4):393–398CrossRefPubMed Kocvara R, Plasgura P, Petrik A et al (1999) A prospective study of nonmedical prophylaxis after a first kidney stone. BJU Int 84(4):393–398CrossRefPubMed
4.
Zurück zum Zitat Bensalah K, Tuncel A, Raman JD et al (2009) How physician and patient perceptions differ regarding medical management of stone disease. J Urol 182(3):998–1004CrossRefPubMed Bensalah K, Tuncel A, Raman JD et al (2009) How physician and patient perceptions differ regarding medical management of stone disease. J Urol 182(3):998–1004CrossRefPubMed
5.
Zurück zum Zitat Parks JH, Asplin JR, Coe FL (2001) Patient adherence to long-term medical treatment of kidney stones. J Urol 166(6):2057–2060CrossRefPubMed Parks JH, Asplin JR, Coe FL (2001) Patient adherence to long-term medical treatment of kidney stones. J Urol 166(6):2057–2060CrossRefPubMed
6.
Zurück zum Zitat Dauw CA, Yi Y, Bierlein MJ et al (2016) Medication nonadherence and effectiveness of preventive pharmacological therapy for kidney stones. J Urol 195(3):648–652CrossRefPubMed Dauw CA, Yi Y, Bierlein MJ et al (2016) Medication nonadherence and effectiveness of preventive pharmacological therapy for kidney stones. J Urol 195(3):648–652CrossRefPubMed
7.
Zurück zum Zitat Hess B (2017) Renal stone clinic survey: calcium stone formers’ self-declared understanding of and adherence to physician’s recommendations. Urolithiasis 45(4):363–370CrossRefPubMed Hess B (2017) Renal stone clinic survey: calcium stone formers’ self-declared understanding of and adherence to physician’s recommendations. Urolithiasis 45(4):363–370CrossRefPubMed
8.
Zurück zum Zitat Ruppar TM (2012) Medication adherence research: essential to improving health. West J Nurs Res 34(5):575–577CrossRefPubMed Ruppar TM (2012) Medication adherence research: essential to improving health. West J Nurs Res 34(5):575–577CrossRefPubMed
9.
Zurück zum Zitat Whitehurst L, Jones P, Somani BK (2019) Mortality from kidney stone disease (KSD) as reported in the literature over the last two decades: a systematic review. World J Urol 37(5):759–776CrossRefPubMed Whitehurst L, Jones P, Somani BK (2019) Mortality from kidney stone disease (KSD) as reported in the literature over the last two decades: a systematic review. World J Urol 37(5):759–776CrossRefPubMed
10.
Zurück zum Zitat Pearle MS, Goldfarb DS, Assimos DG et al (2014) Medical management of kidney stones: AUA guideline. J Urol 192(2):316–324CrossRefPubMed Pearle MS, Goldfarb DS, Assimos DG et al (2014) Medical management of kidney stones: AUA guideline. J Urol 192(2):316–324CrossRefPubMed
12.
Zurück zum Zitat Dauw CA, Alruwaily AF, Bierlein MJ et al (2015) Provider variation in the quality of metabolic stone management. J Urol 193(3):885–890CrossRefPubMed Dauw CA, Alruwaily AF, Bierlein MJ et al (2015) Provider variation in the quality of metabolic stone management. J Urol 193(3):885–890CrossRefPubMed
13.
Zurück zum Zitat Gokce MI, Wang X, Frost J et al (2016) Informed decision making before prostate-specific antigen screening: Initial results using the American Cancer Society (ACS) Decision Aid (DA) among medically underserved men. Cancer 123(4):583–591CrossRefPubMed Gokce MI, Wang X, Frost J et al (2016) Informed decision making before prostate-specific antigen screening: Initial results using the American Cancer Society (ACS) Decision Aid (DA) among medically underserved men. Cancer 123(4):583–591CrossRefPubMed
14.
Zurück zum Zitat Volk RJ, Spann SJ, Cass AR et al (2003) Patient education for informed decision making about prostate cancer screening: a randomized controlled trial with 1-year follow-up. Ann Fam Med 1(1):22–28CrossRefPubMedPubMedCentral Volk RJ, Spann SJ, Cass AR et al (2003) Patient education for informed decision making about prostate cancer screening: a randomized controlled trial with 1-year follow-up. Ann Fam Med 1(1):22–28CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Gokce MI, Esen B, Sanci A et al (2017) A novel decision aid to support informed decision-making process in patients with a symptomatic nonlower pole renal stone <20 mm in diameter. J Endourol 31(7):725–728CrossRefPubMed Gokce MI, Esen B, Sanci A et al (2017) A novel decision aid to support informed decision-making process in patients with a symptomatic nonlower pole renal stone <20 mm in diameter. J Endourol 31(7):725–728CrossRefPubMed
16.
Zurück zum Zitat Hess B, Mauron H, Ackermann D et al (1999) Effects of a “common sense diet” on urinary composition and supersaturation in patients with idiopathic calcium urolithiasis. Eur Urol 36(2):136–143CrossRefPubMed Hess B, Mauron H, Ackermann D et al (1999) Effects of a “common sense diet” on urinary composition and supersaturation in patients with idiopathic calcium urolithiasis. Eur Urol 36(2):136–143CrossRefPubMed
17.
Zurück zum Zitat Sromicki J, Hess B (2020) Simple dietary advice targeting five urinary parameters reduces urinary supersaturation in idiopathic calcium oxalate stone formers. Urolithiasis 48(5):425–433CrossRefPubMedPubMedCentral Sromicki J, Hess B (2020) Simple dietary advice targeting five urinary parameters reduces urinary supersaturation in idiopathic calcium oxalate stone formers. Urolithiasis 48(5):425–433CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Simon ST, Kini V, Levy AE et al (2021) Medication adherence in cardiovascular medicine. BMJ 374:n1493CrossRefPubMed Simon ST, Kini V, Levy AE et al (2021) Medication adherence in cardiovascular medicine. BMJ 374:n1493CrossRefPubMed
19.
Zurück zum Zitat Mignat C, Unger T (1995) ACE inhibitors. Drug interactions of clinical significance. Drug Saf 12(5):334–47CrossRefPubMed Mignat C, Unger T (1995) ACE inhibitors. Drug interactions of clinical significance. Drug Saf 12(5):334–47CrossRefPubMed
Metadaten
Titel
Patient compliance for metabolic evaluation and medical treatment (CoMET) in calcium-oxalate stone patients: prospective study by EULIS eCORE study group
verfasst von
Mehmet İlker Gökce
Selçuk Güven
Kremena Petkova
Tzevat Tefik
Muhammed Arif İbiş
Giray Sönmez
Nariman Gadzhiev
Murat Can Kiremit
Mehmet Ali Karagöz
Luca Villa
Kemal Sarıca
Publikationsdatum
28.09.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 11/2023
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-023-04610-w

Weitere Artikel der Ausgabe 11/2023

World Journal of Urology 11/2023 Zur Ausgabe

Schützt auch die medikamentöse Gewichtsreduktion vor Krebs?

03.06.2024 ASCO 2024 Kongressbericht

Offenbar muss es nicht immer die bariatrische Chirurgie sein, wenn es darum geht, durch deutlichen Gewichtsverlust auch das Krebsrisiko günstig zu beeinflussen. Eine große Kohortenanalyse zur Behandlung mit GLP-1-Agonisten wurde dazu auf der ASCO-Tagung vorgestellt.

Mit dem Seitenschneider gegen das Reißverschluss-Malheur

03.06.2024 Urologische Notfallmedizin Nachrichten

Wer ihn je erlebt hat, wird ihn nicht vergessen: den Schmerz, den die beim Öffnen oder Schließen des Reißverschlusses am Hosenschlitz eingeklemmte Haut am Penis oder Skrotum verursacht. Eine neue Methode für rasche Abhilfe hat ein US-Team getestet.

Patrone im Penis bringt Urologen in Gefahr

30.05.2024 Operationen am Penis Nachrichten

In Lebensgefahr brachte ein junger Mann nicht nur sich selbst, sondern auch das urologische Team, das ihm zu Hilfe kam: Er hatte sich zur Selbstbefriedigung eine scharfe Patrone in die Harnröhre gesteckt.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.